Comparable response rates of venetoclax 50 mg with posaconazole versus venetoclax 400 mg despite lower pharmacokinetic exposure in newly diagnosed acute myeloid leukemia: less is enough.
Saved in:
| Title: | Comparable response rates of venetoclax 50 mg with posaconazole versus venetoclax 400 mg despite lower pharmacokinetic exposure in newly diagnosed acute myeloid leukemia: less is enough. |
|---|---|
| Authors: | Swain, Rudra Narayan1 (AUTHOR), Pattanaik, Smita2 (AUTHOR), Jain, Arihant1 (AUTHOR), Wadhera, Sarthak1 (AUTHOR), Singh, Charanpreet1 (AUTHOR), Khadwal, Alka1 (AUTHOR), Malhotra, Pankaj1 (AUTHOR), Prakash, Gaurav1 (AUTHOR) drgp04@gmail.com |
| Source: | Leukemia & Lymphoma. Nov2025, Vol. 66 Issue 11, p2118-2122. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10428194 |
|---|---|
| DOI: | 10.1080/10428194.2025.2519921 |
